VERX vs. CRSP
Compare and contrast key facts about Vertex, Inc. (VERX) and CRISPR Therapeutics AG (CRSP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VERX or CRSP.
Correlation
The correlation between VERX and CRSP is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VERX vs. CRSP - Performance Comparison
Key characteristics
VERX:
2.55
CRSP:
-0.82
VERX:
3.89
CRSP:
-1.17
VERX:
1.52
CRSP:
0.88
VERX:
3.10
CRSP:
-0.50
VERX:
18.74
CRSP:
-1.06
VERX:
6.56%
CRSP:
38.39%
VERX:
48.22%
CRSP:
50.05%
VERX:
-75.40%
CRSP:
-81.74%
VERX:
-7.04%
CRSP:
-81.74%
Fundamentals
VERX:
$8.25B
CRSP:
$3.27B
VERX:
$0.19
CRSP:
-$2.79
VERX:
$488.32M
CRSP:
$1.62M
VERX:
$302.20M
CRSP:
-$118.31M
VERX:
$59.00M
CRSP:
-$387.56M
Returns By Period
In the year-to-date period, VERX achieves a -0.82% return, which is significantly higher than CRSP's -2.54% return.
VERX
-0.82%
0.99%
39.13%
124.77%
N/A
N/A
CRSP
-2.54%
-12.38%
-38.87%
-40.30%
-8.48%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VERX vs. CRSP — Risk-Adjusted Performance Rank
VERX
CRSP
VERX vs. CRSP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex, Inc. (VERX) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VERX vs. CRSP - Dividend Comparison
Neither VERX nor CRSP has paid dividends to shareholders.
Drawdowns
VERX vs. CRSP - Drawdown Comparison
The maximum VERX drawdown since its inception was -75.40%, smaller than the maximum CRSP drawdown of -81.74%. Use the drawdown chart below to compare losses from any high point for VERX and CRSP. For additional features, visit the drawdowns tool.
Volatility
VERX vs. CRSP - Volatility Comparison
The current volatility for Vertex, Inc. (VERX) is 7.26%, while CRISPR Therapeutics AG (CRSP) has a volatility of 13.72%. This indicates that VERX experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VERX vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between Vertex, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities